"The Joint Parliamentary Committee on the Waqf (Amendment) Bill, 2024 will meet in Delhi on November 21...Then the report will be presented in the winter session...Even after meeting with all the ...
VacSYn is an adaptive, placebo-controlled, and biomarker-based Phase 2 study in patients with early PD ... Forward-looking statements speak only as of the date they are made, and AC Immune does not ...
Despite this ruling Council Leader - Carl Les - says the company have now said they will undertake an environmental study. Europa's decision to voluntarily undertake an environmental assessment has ...